Filing Details

Accession Number:
0001661181-21-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-08 20:03:39
Reporting Period:
2021-06-04
Accepted Time:
2021-06-08 20:03:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074084 Albert Erani C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1760694 Starr Wisdom 44 Wilson Street
Hartsdale NY 10530
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2021-06-04 60,000 $16.22 59,776,745 No 4 S Direct
Class A Common Stock Disposition 2021-06-07 94,612 $16.14 59,682,133 No 4 S Direct
Class A Common Stock Disposition 2021-06-08 100,000 $15.41 59,582,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.30, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. Reflects the total number of securities held by the Group.
  4. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $16.05, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.